During the past decade, Kagoshima City Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 13 clinical trials were completed, i.e. on average, 130% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kagoshima City Hospital" #1 sponsor was "Gynecologic Oncology Group" with 7 trials, followed by "National Cancer Institute (NCI)" with 7 trials sponsored, "GOG Foundation" with 3 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kagoshima City Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Kagoshima City Hospital" are "Ovarian Cancer" (5 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials), "Ovarian Clear Cell Adenocarcinoma" (4 trials) and "Ovarian Transitional Cell Carcinoma" (4 trials). Many other conditions were trialed in "Kagoshima City Hospital" in a lesser frequency.

Most popular intervention types in "Kagoshima City Hospital" are "Drug" (26 trials), "Other" (10 trials), "Biological" (9 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Paclitaxel" (7 trials), "Quality-of-Life Assessment" (7 trials), "Carboplatin" (6 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kagoshima City Hospital" are 23 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Kagoshima City Hospital". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Kagoshima City Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kagoshima City Hospital, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".